Person profile
Krishna Polu
A Stanford-trained physician and nephrologist with over two decades of biopharmaceutical experience. Raised over $750M with a track record including two exits and multiple company formations. Now developing first-in-class treatments for patients with chronic kidney disease
- Founded
- R1 Therapeutics
- Education
- University of Colorado Anschutz, Stanford University
Companies founded
Currently
Active roles, board seats and partnerships.
Alliance for Lupus Research
Catalys Pacific
Work history
Past roles by Dealroom records.
Commit Biologics
→
Sardona Therapeutics
Bicara Therapeutics
→
Equillium
→
Scout Bio
→
Frazier Healthcare Partners
CytomX Therapeutics
→
Alantos Pharmaceuticals
→
Education
University of Colorado Anschutz
Stanford University